Intra-Cellular Therapies SG&A Expenses 2013-2024 | ITCI

Intra-Cellular Therapies sg&a expenses for the twelve months ending September 30, 2024 were $0.471B, a 17.94% increase year-over-year.

  • Intra-Cellular Therapies annual sg&a expenses for 2023 were $0.41B, a 14.24% increase from 2022.
  • Intra-Cellular Therapies annual sg&a expenses for 2022 were $0.359B, a 31.61% increase from 2021.
  • Intra-Cellular Therapies annual sg&a expenses for 2021 were $0.273B, a 46.28% increase from 2020.

Intra-Cellular Therapies SG&A Expenses 2013-2024 | ITCI

  • Intra-Cellular Therapies annual sg&a expenses for 2023 were $0.41B, a 14.24% increase from 2022.
  • Intra-Cellular Therapies annual sg&a expenses for 2022 were $0.359B, a 31.61% increase from 2021.
  • Intra-Cellular Therapies annual sg&a expenses for 2021 were $0.273B, a 46.28% increase from 2020.